Multicenter Phase Ii Trial Of Patients With Refractory Or Recurrent Multiple Myeloma With Oral Treatment Of Thalidomide Combined With Oral Cyclophosphamide, Idarubicin And Dexamethasone

Axel Glasmacher,Thomas Moehler,Hartmut Goldschmidt,Thomas Geer,Rolf Kleinschmidt,Tobias Gaska,Janssens Uwe, Jorg Schubert, Patrick Bruck,Michael R. Clemens, Wolfgang Bair, Gernot Seipelt,Michael Schleuning,Corinna Hahn-Ast,Susanne Herz,Marie Von Lilienfeld-Toal, Ralf Naumann,Marcus Gorschluter,Ingo G. H. Schmidt-Wolf

BLOOD（2007）

引用 0|浏览9

暂无评分

摘要

Introduction and rationale: The aim of our study is to evaluate the role of thalidomide in combination with oral CID therapy in order to improve treatment wit an all oral regime.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要